title: Quality of Life in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization.
abstract: Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed cancers worldwide. Majority of patients with HCC are diagnosed in the advanced stages of disease and hence they are only suitable for palliative therapy. TACE (transarterial chemoembolization) is the most commonly used treatment for unresectable HCC. It is however unclear if TACE improves the quality of life (QoL) in patients with HCC. The aim of this review is to evaluate the impact of TACE on QoL of HCC patients.
authors.affiliation: Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433; Ministry of Health Holdings, 1 Maritime Square, Singapore 099253.
authors.forename: Saleem
authors.initials: S
authors.lastname: Ahmed
authors.affiliation: Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857; Singapore Clinical Research Institute, 31 Biopolis Way, Singapore 138669.
authors.forename: Nurun Nisa
authors.initials: NN
authors.lastname: de Souza
authors.affiliation: Ministry of Health Holdings, 1 Maritime Square, Singapore 099253.
authors.forename: Wang
authors.initials: W
authors.lastname: Qiao
authors.affiliation: Department of Gastroenterological Surgery, Sendai Kousei Hospital, 8-15 Hirosemachi, Aoba-ku, Sendai-shi, Miyagi 9800873, Japan.
authors.forename: Meidai
authors.initials: M
authors.lastname: Kasai
authors.affiliation: Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433.
authors.forename: Low Jee
authors.initials: LJ
authors.lastname: Keem
authors.affiliation: Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433.
authors.forename: Vishal G
authors.initials: VG
authors.lastname: Shelat